À retenir
In 72 studies with 7949 participants, wearables used at home to monitor movement were generally well accepted, with compliance of 70% or more and strong agreement with clinical assessments. Only half of the studies were controlled trials and just 5.6% were randomised, so evidence that they improve care is limited.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Wearables could monitor motor symptoms and activity continuously outside the clinic, yet clinicians rarely adopt them, partly because of low awareness and confidence. The authors reviewed how wearables are used for continuous motor monitoring at home, and how feasible and effective they are in neurological, musculoskeletal and rheumatologic conditions.
Population et méthode
Systematic review following PRISMA guidelines, searching PubMed, Scopus and Web of Science. 72 studies with 7949 participants met inclusion criteria. The review looked at purpose, sensor type, feasibility and effectiveness. The abstract does not report the search dates or the quality assessment.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Neurological disorders, especially Parkinson's disease, were the most studied. Common sensors were inertial measurement units (IMUs), accelerometers and gyroscopes in medical devices, smartwatches or smartphones.
- 2Monitoring periods ranged from 24 h to over two years.
- 3Feasibility studies reported high patient compliance (70% or more), good acceptance, and strong agreement with clinical assessments.
- 4Only half of the studies were controlled trials, and just 5.6% were randomised.
Limites et incertitude
- 1Studies were very varied in condition, device and monitoring length, so there is no single pooled estimate of effectiveness.
- 2Few randomised trials means little direct evidence that home monitoring changes treatment or outcomes.
- 3The abstract names ethical issues, data privacy, standardisation and healthcare access as unresolved, and its remark that artificial intelligence may boost accuracy is a forecast, not a finding.
- 4This reading is based on the abstract only.
Mise en perspective
Wearing a motion sensor at home is generally tolerable for people with movement problems and tends to agree with clinic assessments, but this review does not show it improves health. If you have a movement disorder, share any sensor data with your clinician rather than acting on it alone.
Vos données
Daily step counts, activity minutes and gait-related metrics from a watch or phone are consumer versions of what these studies tracked. Use the same device and wear position, and compare weeks rather than single days.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Wearable sensors are a promising tool for the remote, continuous monitoring of motor symptoms and physical activity, especially in individuals with neurological or chronic conditions. Despite many experimental trials, clinical adoption remains limited. A major barrier is the lack of awareness and confidence among healthcare professionals in these technologies.
Methods
This systematic review analyzed the use of wearable sensors for continuous motor monitoring at home, focusing on their purpose, type, feasibility, and effectiveness in neurological, musculoskeletal, or rheumatologic conditions. This review followed PRISMA guidelines and included studies from PubMed, Scopus, and Web of Science.
Results
Seventy-two studies with 7949 participants met inclusion criteria. Neurological disorders, particularly Parkinson's disease, were the most frequently studied. Common sensors included inertial measurement units (IMUs), accelerometers, and gyroscopes, often integrated into medical devices, smartwatches, or smartphones. Monitoring periods ranged from 24 h to over two years. Feasibility studies showed high patient compliance (≥70%) and good acceptance, with strong agreement with clinical assessments. However, only half of the studies were controlled trials, and just 5.6% were randomized.
Conclusions
Wearable sensors offer strong potential for real-world motor function monitoring. Yet, challenges persist, including ethical issues, data privacy, standardization, and healthcare access. Artificial intelligence integration may boost predictive accuracy and personalized care.
Sources et attribution
Continuous Movement Monitoring at Home Through Wearable Devices: A Systematic Review.
Farabolini G, Baldini N, Pagano A, Andrenelli E, Pepa L, Morone G, Ceravolo MG, Capecci M.
Sensors (Basel, Switzerland) · 2025-08-08
DOI: 10.3390/s25164889 ↗PubMed · 40871752 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

